Not logged in.png)
Share.png)
SaveShare Save Anlotinib Plus Docetaxel is Promising in Advanced NSCLC Progressing on First-Line Immunotherapy: A Pooled Analysis of Two Randomized Trials
Pu, XX; Shou, JW; Xiao, ZM; Chen, J; Xiao, ML; Guo, QY; Ma, ZX; Hong, W; Wang, QZ; Wang, YH; Li, J; Rao, CZ; Weng, J; Lu, LQ; Wu, L; Fang, Y Share Save Share Save Share Save PAM-Independent CRISPR-Cas12a System for Specific Assays of Single Nucleotide VariantsAi, Jinlong; Deng, Jinhai; Hu, Jingjing; Pu, Xingxiang; Yuan, Tongyan; Teng, Yuling; Li, Han; Chen, Bojie; Du, Jinlian; Jiang, Ling; Chen, Xiaoyan; Xiong, Erhu; Yang, Ronghua Share Save A prognostic index for advanced-stage extranodal natural killer/T-cell lymphoma: A multicenter studyFang, Xiaojie; Zhou, Fenglan; Ye, Sheng; Zhang, Hongyu; Guo, Hongqiang; Chen, Xinggui; Liang, Chaoyong; Pu, Xingxiang; Cao, Yabing; Ren, Quanguang; Li, Xiaoqian; Zhai, Linzhu; Huang, He; Hong, Huangming Share Save Expert consensus on the diagnosis and treatment of solid tumors with BRAF mutationsWang, Wenxian; Lian, Bin; Xu, Chunwei; Wang, Qian; Li, Ziming; Zheng, Nan; Liu, Aijun; Yu, Jinpu; Zhong, Wenzhao; Wang, Zhijie; Zhang, Yongchang; Liu, Jingjing; Zhang, Shirong; Cai, Xiuyu; Liu, Anwen; Li, Wen; Mao, Lili; Zhan, Ping; Liu, Hongbing; Lv, Tangfeng; Miao, Liyun; Min, Lingfeng; Chen, Yu; Yuan, Jingping; Wang, Feng; Jiang, Zhansheng; Lin, Gen; Huang, Long; Pu, Xingxiang; Lin, Rongbo; Rao, Chuangzhou; Lv, Dongqing; Yu, Zongyang; Li, Xiaoyan; Tang, Chuanhao; Zhou, Chengzhi; Zhang, Junping; Xue, Junli; Guo, Hui; Chu, Qian; Liu, Xuewen; Wu, Jingxun; Zhang, Rui; Zhou, Jin; Zhu, Zhengfei; Li, Yongheng; Qiu, Hong; Xia, Fan; Lu, Yuanyuan; Chen, Xiaofeng; Feng, Jian; Ge, Rui; Dai, Enyong; Pan, Weiwei; Pang, Fei; Huang, Xin; Hu, Meizhen; Hao, Qing; Wang, Kai; Wu, Fan; Song, Binbin; Xu, Bingwei; Wang, Liping; Zhu, Youcai; Lin, Li; Xie, Yanru; Lin, Xinqing; Cai, Jing; Xu, Ling; Li, Jisheng; Jiao, Xiaodong; Li, Kainan; Wei, Jia; Feng, Huijing; Wang, Lin; Du, Yingying; Yao, Wang; Shi, Xuefei; Niu, Xiaomin; Yuan, Dongmei; Yao, Yanwen; Huang, Jianhui; Feng, Yue; Zhang, Yinbin; Sun, Pingli; Wang, Hong; Ye, Mingxiang; Wang, Dong; Wang, Zhaofeng; Hao, Yue; Wang, Zhen; Wan, Bin; Lv, Donglai; Yang, Shengjie; Kang, Jin; Zhang, Jiatao; Zhang, Chao; Li, Wenfeng; Fu, Jianfei; Wu, Lizhi; Lan, Shijie; Ou, Juanjuan; Shi, Lin; Zhai, Zhanqiang; Wang, Yina; Li, Bihui; Zhang, Zhang; Wang, Ke; Ma, Xuelei; Li, Zhongwu; Liu, Zhefeng; Yang, Nong; Wu, Lin; Wang, Huijuan; Jin, Gu; Wang, Guansong; Wang, Jiandong; Fang, Meiyu; Fang, Yong; Li, Yuan; Wang, Xiaojia; Chen, Jing; Zhang, Yiping; Zhu, Xixu; Shen, Yi; Ma, Shenglin; Wang, Biyun; Song, Yong; Song, Zhengbo; Si, Lu Share Save ADAMTS4 exacerbates lung cancer progression via regulating c-Myc protein stability and activating MAPK signaling pathwayZhai, Wei; Yang, Wensheng; Ge, Jing; Xiao, Xuelian; Wu, Kang; She, Kelin; Zhou, Yu; Kong, Yi; Wu, Lin; Luo, Shiya; Pu, Xingxiang Share Save Efficacy in patients with EGFR-positive non-small-cell lung cancer treated with dacomitinib who had skin adverse events: post hoc analyses from ARCHER 1050Pu, Xingxiang; Li, Juan; Zhang, Bo; Zhang, Jinyao; Mok, Tony S.; Nakagawa, Kazuhiko; Rosell, Rafael; Cheng, Ying; Zhou, Xiangdong; Miglorino, Maria Rita; Niho, Seiji; Lee, Ki Hyeong; Corral, Jesus; Pluzanski, Adam; Li, Junling; Linke, Rolf; Pan, Fang; Tang, Yiyun; Tan, Weiwei; Wu, Lin Share Save Circulating tumor DNA minimal residual disease predicts the risk of progression after long-term response to first-line immunotherapy in advanced NSCLCWu, F.; Peng, Y.; Zeng, Y.; Qiu, Z.; Ma, F.; Zhu, L.; Zhou, C.; Pu, X.; Zhang, L.; Zhou, Y.; Weng, J.; Zengmei, S.; Yu, J.; Zhou, Z.; Meng, R.; Bu, Q.; Liu, P.; Li, J.; Chen, S.; Cui, L. Share Save Camrelizumab combined with apatinib and nanoparticle albumin-bound paclitaxel in lung adenocarcinoma (CAPAP-lung): a single-arm phase II studyPu, Xingxiang; Lin, Gen; Xiao, Maoliang; Lin, Jie; Wang, Qianzhi; Kong, Yi; Yan, Xuejun; Xu, Fang; Xu, Yan; Li, Jia; Li, Kang; Chen, Bolin; Wen, Xiaoping; Tan, Yali; Cheng, Fengzhuo; Zhu, Kangle; Li, Na; Wu, Lin Share Save A phase Ib/II study of cadonilimab (PD-1/CTLA-4 bispecific antibody) plus anlotinib as first-line treatment in patients with advanced non-small cell lung cancerChen, Bolin; Yao, Wenxiu; Li, Xingya; Lin, Gen; Chu, Qian; Liu, Hailong; Du, Yingying; Lin, Jie; Duan, Huaxin; Wang, Huijuan; Xiao, Zemin; Sun, Hong; Liu, Liyu; Xu, Li; Xu, Yan; Xu, Fang; Kong, Yi; Pu, Xingxiang; Li, Kang; Wang, Qianzhi; Li, Jia; Li, Baiyong; Xia, Yu; Wu, Lin Share Save Share Save The role of radiotherapy in extensive-stage small cell lung cancer after durvalumab-based immunochemotherapy: A retrospective studyChen, L.; Tong, F.; Kong, Y.; Zhang, R.; Ding, P.; Zhang, S.; Wang, Y.; Zhou, R.; Pu, X.; Chen, B.; Liang, F.; Tan, Q.; Xu, Y.; Wu, L.; Dong, X. Share Save The clinical and genomic distinctions of Class1/2/3 BRAF-mutant colorectal cancer and differential prognosesChen, Yungchang; Sun, Hao; Deng, Yanhong; Ma, Yutong; Huang, He; Liu, Yang; Zhang, Yaru; Zhang, Hongyu; Ye, Sheng; Mingyan, E.; Guo, Hongqiang; Wu, Mengmeng; Wu, Chunman; Pu, Xingxiang; Chen, Xinggui; Liang, Chaoyong; Ou, Qiuxiang; Weng, Huawei; Wu, Xue; Shao, Yang; Gu, Anxin; Lin, Tongyu Share Save Utility of cell-free DNA from bronchial washing fluid in diagnosis and genomic determination for radiology-suspected pulmonary nodulesZhang, Xinyu; Yu, Zhuo; Xu, Yaping; Chao, Yencheng; Hu, Qin; Li, Chun; Ye, Maosong; Zhu, Xiuli; Cui, Liang; Bai, Jing; Gong, Yuhua; Guan, Yanfang; Zhou, Min; Huang, Jian'an; Zhang, Hua; Ren, Tao; Shen, Qian; Wang, Kai; Hou, Yingyong; Xia, Xuefeng; Pu, Xingxiang; Carbone, David P.; Zhang, Xin Share Save The efficacy and safety of immune checkpoint inhibitors combined with chemotherapy or anti-angiogenic therapy as a second-line or later treatment option for advanced non-small cell lung cancer: a retrospective comparative cohort studyChen, Bolin; Wang, Jingyi; Pu, Xingxiang; Li, Jia; Wang, Qianzhi; Liu, Liyu; Xu, Yan; Xu, Li; Kong, Yi; Li, Kang; Xu, Fang; Liang, Shuzhi; Cardona, Andres F.; Wu, Lin Share Save Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
